Audited Unaudited
Financial Year Ended 31 December 2013 2014 2015 2016 2017
No. of Months 12 12 12 12 9
KEY FINANCIALS
STATEMENT OF COMPREHENSIVE INCOME
Revenue RM'000 24,570 27,115 29,720 47,123 35,876
Earnings Before Interest, Tax, Depreciation & Amortisation (EBITDA) RM'000 10,361 10,182 12,136 13,752 8,836
Profit Before Taxation (PBT) RM'000 7,540 6,786 7,303 7,737 3,664
Profit After Taxation (PAT) RM'000 6,338 6,297 6,458 7,924 3,492
 
RATIO ANALYSIS
PER SHARE DATA
Gross Earnings Per Share (Gross EPS) (1) sen 3.50 3.63 3.47 2.92 1.89
Net Earnings Per Share (Net EPS) (2) sen 1.73 1.77 1.47 1.27 0.45
Basic Earnings Per Share (Basic EPS) (3) sen 2.47 1.77 1.12 1.28 0.47
 
PROFITABILITY
PBT Margin % 30.69 25.03 24.57 16.24 10.21
PAT Margin % 25.80 23.22 21.73 16.82 9.73
 
WORKING CAPITAL RATIOS
Trade Receivables Turnover (4) days 191 174 197 187 214
Trade Payables Turnover (5) days 59 27 11 32 75
Inventory Turnover (6) days 79 115 168 103 146
 
Number of Shares in issue ('000) shares 363,413 363,413 463,413 666,666 808,149
Weighted Average Number of Ordinary Shares ('000) shares 254,383 363,413 604,599 663,601 782,302

Notes:-

(1) Calculated based on gross profit divided by the number of Shares in issue.
(2) Calculated based on net profit attributable to owners of the parent divided by the number of Shares in issue.
(3) Calculated based on net profit attributable to owners of the parent divided by the weighted average number of ordinary shares in issue.
(4) Calculated based on: Average trade receivables/Total revenue x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016
(5) Calculated based on: Average trade payables/Total cost of sales (excluded depreciation & amortisation) x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016
(6) Calculated based on: Average inventories/Total cost of sales (excluded depreciation & amortisation) x 365 days for FYE 2012 to FYE 2015 and 274 days for FPE 30 September 2016

* Please read this section in conjunction with Bioalpha Holdings Berhad's Prospectus dated 26 March 2015, Annual Reports and the latest Quarterly Report.